Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics - Wikidata - wikimedia - TriplyDB

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

http://www.wikidata.org/entity/Q33806168

about

Novel Analysis of the Oral Treprostinil Combination Therapy Trial Data.Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension.Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation.The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension.Oral treprostinil in the treatment of pulmonary arterial hypertension.8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain.Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension.

P2860

Q31108228-5AA3E2D0-006C-4C3F-ADA6-C349E226310A Q34508259-C5D819B7-7E4B-4AAC-BCA6-C15A6935DDDF Q38692032-69D033CE-C405-4588-B632-D6CA23F12D6A Q38841958-DA6E95BC-C6E4-4E43-9EE8-EE12EB625D4C Q45960565-343E4365-CCFF-41AF-AC9C-723965CEA2B6 Q47784063-E37D99CF-A233-4C34-AD27-592117E2E681 Q55044771-1139CC22-DD20-49FD-87FA-FF1B33722195 Q55286186-2715DEEE-D3CB-4C3D-A110-2C2A761798B2

P2860

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

http://www.wikidata.org/entity/Q33806168

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

@ast

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

@en

type

label

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

@ast

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

@en

prefLabel

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

@ast

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

@en

P1433

Q33806168-B4E8A04B-E27D-4515-A3A7-F8C3D7FA531B

P1476

Q33806168-880F19E5-D287-449A-A8C3-48F97AE5C7BE

P2093

Q33806168-04463352-8306-4DC8-851F-2FBD92D3FD77

Q33806168-06E19094-215D-4AEC-AE11-E1190FAB27C5

Q33806168-1AF55CCB-24FB-41CD-B62C-DE88BEB9C8E9

Q33806168-BFB0F62E-9DE4-4DC1-B898-3C4482EEA8D4

Q33806168-FCF56F9C-6663-4948-889B-6DDB0707BEB4

P2860

Q33806168-02582F5F-59D7-4723-9719-4E55CCDA9FC3

Q33806168-0744B2BB-9D74-4D4D-AB4E-8FA3A7A16191

Q33806168-199A8BD6-D62B-4042-9902-0DFC33052D3F

Q33806168-259B1243-8EAD-4281-8FF7-D8E1305F8105

Q33806168-27D10AE1-0DD4-485D-BDD3-BD51F5C85B0F

Q33806168-29F0FF58-0F7F-4900-A21F-F1E2E056FA8F

Q33806168-44B73396-36C6-49EE-9CCF-C1EDC4F09891

Q33806168-47601504-0B91-407D-BA22-D591FA5C1D08

Q33806168-5061CB0C-D01C-4FE4-85C3-816382F17BCC

Q33806168-52010CBD-6ADA-49C5-B87C-4FFE7B443F58

P304

Q33806168-299DB3F9-3F62-49AE-BCD8-356D68AEF7AD

P31

Q33806168-D488BCF9-6188-4DD4-A40E-C4EFBDDE49DC

P356

Q33806168-F5B5E1AA-CD62-4C39-9813-A107F66B9B1D

P433

Q33806168-5F1BD614-D9BC-4D1A-9865-E3ACEFA12FDD

P478

Q33806168-B610E42A-F082-4543-8EEF-D8552E086C10

P577

Q33806168-35F14135-17B6-4340-A013-800F69E6B8FE

P5875

Q33806168-B6070C77-3331-436D-8A92-7F5FAB05158D

P698

Q33806168-68C25846-15D1-4D0C-AA6D-E8A4E4F9D164

P932

Q33806168-8860319D-5AE4-430A-9803-408D5DC72F1B

P356

P1433

Pulmonary circulation

P1476

Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics

@en

P2093

Antonia Heininger

http://www.w3.org/2001/XMLSchema#string

Karen Frutiger

http://www.w3.org/2001/XMLSchema#string

Kathleen Wessman

http://www.w3.org/2001/XMLSchema#string

R James White

http://www.w3.org/2001/XMLSchema#string

Yana Levin

http://www.w3.org/2001/XMLSchema#string

P2860

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.

Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations.

P304

611-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/674304

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260717431

http://www.w3.org/2001/XMLSchema#string

P698

24618545

http://www.w3.org/2001/XMLSchema#string

P932

4070817

http://www.w3.org/2001/XMLSchema#string